Delphinus Medical Technologies
- Company typePrivate
- Founded2010
- HeadquartersNovi, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
Delphinus Medical Technologies firmographics
Firmographics- Name
- Delphinus Medical Technologies
- Legal name
- Delphinus Medical Technologies, Inc.
- Website
- https://delphinusmt.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
Delphinus Medical Technologies industry classification
Industry- Product category
- Breast Imaging Systems
- NAICS
- Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Mammography & Breast Imaging Systems (HLAHABAF)
- akta.pro secondary industries
- Breast Imaging Centers (Mammography/Tomosynthesis) (HLAFAKAD), Women’s Imaging & Breast Health Centers (HLAFAJAJ)
Keywords
Where Delphinus Medical Technologies is headquartered
LocationHeadquarters
- HQ city
- Novi
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Delphinus Medical Technologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- SoftVue System Sales: Sale of SoftVue 3D Whole Breast Ultrasound Tomography medical imaging systems to hospitals, breast imaging centers, and healthcare facilities. The system is sold as capital equipment with associated consumables (Sequr Breast Interface pads). Revenue recognized upon system installation and acceptance.
- Medical Device Billing (CPT 76641): SoftVue procedures are billed under existing insurance code CPT 76641 for whole breast ultrasound. Healthcare providers purchase/lease the equipment and generate revenue through insurance reimbursement for screening procedures performed on patients.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
Delphinus Medical Technologies product offering
Product offeringCore offering
Delphinus Medical Technologies develops, manufactures, and commercializes the SoftVue 3D Whole Breast Ultrasound Tomography System, an FDA PMA-approved imaging device used as an adjunct to mammography for screening women with dense breast tissue. The system is sold as capital equipment to hospitals and breast imaging centers, along with disposable Sequr Breast Interface consumables used during each scan.
Product overview
Delphinus Medical Technologies offers a single core product platform—the SoftVue 3D Whole Breast Ultrasound Tomography System—designed specifically for dense breast cancer screening. The FDA-approved system uses proprietary TriAD (Triple Acoustic Detection) technology with a 360-degree ring transducer containing over 2,000 elements. When combined with standard mammography, SoftVue identifies up to 20-25% more cancers with greater accuracy. The system requires no radiation or breast compression and is approved for same-day screening alongside mammography. A配套 consumable, the Sequr Breast Interface, is used during each scan procedure.
Differentiator
Problem solved
Functional benefit
Brands
- SoftVue™: FDA-approved 3D Whole Breast Ultrasound Tomography System for screening women with dense breasts as adjunct to digital mammography. Features proprietary TriAD technology with 360-degree ring transducer.
- TriAD™
- Sequr™ Breast Interface
Products and services
- SoftVue 3D Whole Breast Ultrasound Tomography System FDA PMA-approved 3D whole breast ultrasound tomography system using proprietary TriAD (Triple Acoustic Detection) technology with a 360-degree ring transducer containing over 2,000 elements to capture reflection, sound speed, and attenuation signals. Indicated as an adjunct to digital mammography for screening asymptomatic women with dense breast tissue. Requires no radiation or breast compression and is approved for same-day screening alongside mammography.
- Sequr Breast Interface
Quantifiable outcome
- Identifies up to 20-25% more cancers when combined with mammography
- +4 more outcomes
Companies that use Delphinus Medical Technologies
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles2 records
Delphinus Medical Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Delphinus Medical Technologies partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Premier, Inc.coreDelphinus awarded national group purchasing agreement and Technology Breakthrough designation from Premier. SoftVue is now listed as a top supplier for Premier's members, who can access special pricing and terms pre-negotiated by Premier. Premier is a leading healthcare improvement company uniting approximately 4,350 U.S. hospitals and 300,000 other providers. SoftVue was featured at Premier's Breakthroughs24 annual conference as one of the 'latest and greatest' technologies.
- Karmanos Cancer InstitutecoreOriginal research institution where SoftVue technology was conceived and developed. Delphinus was founded as a spin-out of Karmanos in 2010. Karmanos was the first customer to purchase and install SoftVue.
- National Cancer Institute (NIH)coreSupported clinical study comparing whole breast ultrasound tomography and mammography for breast cancer risk assessment through a contract. Study conducted by researchers from NCI, Karmanos Cancer Institute, Wayne State University, Henry Ford Health Systems, Mayo Clinic, and George Washington University.
Scale indicators7 records
Recent moves7 records
Expansion highlights5 records
Delphinus Medical Technologies competitors and assessment
Company assessmentBroad incumbents
- Hologic: Dominant player in breast imaging with the Selenia Dimensions mammography platform and 3Dimensions systems. Directly comparable as the leading supplier of breast cancer screening equipment to the same hospital and imaging center customer base, and competes with SoftVue as the incumbent mammography modality.
- Siemens Healthineers: Mammography OEM with the MAMMOMAT platform and broader breast imaging portfolio including ultrasound and MRI. Competes for the same capital equipment budget at hospitals and breast imaging centers.
- Fujifilm Healthcare: Provides the Aspire Cristalle mammography system and breast imaging solutions to hospitals and imaging centers. Competes directly for breast imaging capital equipment purchases.
- Koninklijke Philips: Major medical imaging OEM with mammography, ultrasound, and MRI breast imaging offerings, including dedicated breast MRI systems. Competes for hospital breast imaging capital budget and serves the same screening and diagnostic workflows.
- GE HealthCare: Large incumbent with Senographe mammography systems and the Invenia Automated Breast Ultrasound (ABUS) system, which is a primary competing modality for dense-breast supplemental screening. Targets the same hospital and breast imaging center buyers.
Emerging players
- Seno Medical Instruments: Developed the Imagio optoacoustic/ultrasound breast imaging system for diagnostic breast imaging. Comparable as a novel breast imaging modality targeting improved characterization of breast lesions, particularly in dense tissue.
- ScreenPoint Medical: Provides AI-powered breast imaging software (Transpara) for mammography triage and decision support, including for dense-breast cases. Adjacent competitor helping radiologists interpret mammograms more effectively in dense tissue.
- QT Imaging: Developer of a no-radiation, no-compression breast imaging system using ultrasound tomography. Most direct technological peer to SoftVue as a competing radiation-free breast imaging modality with similar patient experience positioning.
Direct peers
- iCAD: Provides AI-based breast cancer detection and risk assessment software (ProFound AI) used alongside mammography, including for dense-breast assessment. Comparable in addressing the dense-breast screening workflow with a different technology approach (AI on mammograms vs. ultrasound tomography).
- Volpara Health: Provides breast density assessment and risk evaluation software integrated into mammography workflows. Targets the same dense-breast screening use case with a complementary software-based approach to identifying patients who need supplemental screening.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Delphinus Medical Technologies social profiles
Digital presenceDelphinus Medical Technologies compliance and trust
Trust signalCompliance2 records
Delphinus Medical Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Delphinus Medical Technologies leadership team
Management profileNumber of profiles
Profiles8 records
Delphinus Medical Technologies funding detail
Funding detailFunding overview
Funding rounds6 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Delphinus Medical Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Delphinus Medical Technologies
What does Delphinus Medical Technologies do?
Delphinus Medical Technologies develops, manufactures, and commercializes the SoftVue 3D Whole Breast Ultrasound Tomography System, an FDA PMA-approved imaging device used as an adjunct to mammography for screening women with dense breast tissue. The system is sold as capital equipment to hospitals and breast imaging centers, along with disposable Sequr Breast Interface consumables used during each scan.
Is Delphinus Medical Technologies a public or private company?
Delphinus Medical Technologies is a private company. It is classified as venture growth investor backed and is currently operating.
When was Delphinus Medical Technologies founded?
Delphinus Medical Technologies was founded in 2010. It employs 51 to 100 people.
Where is Delphinus Medical Technologies based?
Delphinus Medical Technologies is headquartered in Novi, United States, in the North America region.
How does Delphinus Medical Technologies make money?
Two revenue lines are on record. SoftVue System Sales are the primary driver. The others are medical Device Billing (CPT 76641).
Who are Delphinus Medical Technologies's main competitors?
Broad incumbents on record are Hologic, Siemens Healthineers, Fujifilm Healthcare, Koninklijke Philips and GE HealthCare. Emerging players are Seno Medical Instruments, ScreenPoint Medical and QT Imaging. Direct peers are iCAD and Volpara Health.
Does Delphinus Medical Technologies have an API?
No public API is recorded for Delphinus Medical Technologies.
What industry is Delphinus Medical Technologies in?
Delphinus Medical Technologies's product category is Breast Imaging Systems. Its primary akta.pro industry code is HLAHABAF, Mammography & Breast Imaging Systems, with a secondary code of HLAFAKAD, Breast Imaging Centers (Mammography/Tomosynthesis). Its NAICS code is 339112 and its SIC code is 3841.